ARCHIVES

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

This article is from The Cancer Letter archive.

Vol. 05 No. 11 | March 16, 1979

Download PDF Visit The Full Archive

Related Articles

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Four New Centers To Compete In ’84, DeVita Tells Pane

December 16, 1983

Three Fourths Of Pediatric Patients are Getting Best Treatment; NCI Goal: Reach all The Others

May 20, 1977

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984